Evidence map›Paper›PMID 38398882›Full record

ArticleNutrients2024

Vitamin D Status, VDR, and TLR Polymorphisms and Pulmonary Tuberculosis Epidemiology in Kazakhstan.

Dauren Yerezhepov, Aidana Gabdulkayum, Ainur Akhmetova, Ulan A Kozhamkulov, Saule E Rakhimova, Ulykbek Y Kairov, Gulnur Zhunussova, Ruslan N Kalendar, Ainur Akilzhanova

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. FokI Polymorphism of theNutrients · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Vitamin D receptorTherapeutic advances in infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Dauren YerezhepovLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0002-4161-1348
Aidana GabdulkayumLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0003-1551-3637
Ainur AkhmetovaLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
Ulan A KozhamkulovLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
Saule E RakhimovaLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
Ulykbek Y KairovLaboratory of Bioinformatics and Systems Biology, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-8511-8064
Gulnur ZhunussovaInstitute of Genetics and Physiology, Almaty 020000, Kazakhstan.
Ruslan N KalendarInstitute of Biotechnology HiLIFE, University of Helsinki, P.O. Box 65, 00014 Helsinki, Finland.ORCID 0000-0003-3986-2460
Ainur AkilzhanovaLaboratory of Genomic and Personalized Medicine, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-6161-8355
Nazarbayev University · KZInstitute of Plant Biology and Biotechnology · KZUniversity of Helsinki · FI

Funding

Nazarbayev University under the Collaborative Research Program 11022021CRP1511Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan АР09058217
6 · The paper itself

Abstract

backgroundTuberculosis (TB) and vitamin D deficiency remain major public health problems in Kazakhstan. Due to the high incidence of pulmonary tuberculosis in the country and based on the importance of vitamin D in the modulation of the immune response and the association of its deficiency with many health conditions, the aim of our research was to study the vitamin D status, VDR and TLR gene polymorphisms, and pulmonary tuberculosis epidemiology in Kazakhstan.

methodsA case-control study included 411 individuals diagnosed with pulmonary TB and 686 controls with no family history of pulmonary tuberculosis. Concentrations of serum vitamin D (25-(OH)D) levels were measured by electrochemiluminescence immunoassay. The gene polymorphisms were determined by real-time polymerase chain reaction (PCR) allelic discrimination assay using TaqMan probes. The association between the risk of pulmonary TB and polymorphisms was evaluated using multimodal logistic regression and assessed with the ORs, corresponding to 95% Cis, and the significance level was determined as

results1097 individuals were recruited from 3 different regions of Kazakhstan. Biochemical data showed vitamin D deficiency (25-(OH)D < 20 ng/mL) was present in both groups, with the case group accounting for almost 95% and 43.7% in controls. Epidemiological data revealed that socioeconomic factors such as BMI < 25 kg/m

conclusionsVitamin D deficiency remains prevalent in our study cohort and is associated with TB progression. Socioeconomic determinants such as unemployment, BMI under 25 kg/m

Indexed as

Diabetes MellitusTuberculosisTuberculosis, PulmonaryVitamin D DeficiencyCase-Control StudiesGenetic Predisposition to DiseaseGenotypeHumansKazakhstanPolymorphism, GeneticPolymorphism, Single NucleotideReceptors, CalcitriolToll-Like Receptor 8Vitamin DVitaminsReceptors, CalcitriolToll-Like Receptor 8VDR protein, humanVitamin DVitaminsepidemiologyinfectious diseasepulmonary tuberculosisrisk factorsvitamin D deficiency

Identifiers

PMID38398882
PMCPMC10892443
OpenAlexW4391961677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.